Clinical effectiveness of decitabine in severe sickle cell disease.
Saunthararajah
Yogen
Y
Molokie
Robert
R
Saraf
Santosh
S
Sidhwani
Seema
S
Gowhari
Michel
M
Vara
Steven
S
Lavelle
Donald
D
DeSimone
Joseph
J
D000328:Adult; D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015254:DNA Modification Methylases / Q000037:antagonists & inhibitors; D000077209:Decitabine; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D016896:Treatment Outcome
D004791:Enzyme Inhibitors; D000077209:Decitabine; D015254:DNA Modification Methylases; D001374:Azacitidine